Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
about
Impact of New Genomic Technologies on Understanding Adverse Drug ReactionsNew genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivityPharmacogenetics and Predictive Testing of Drug Hypersensitivity ReactionsTreatment-resistant schizophrenia: current insights on the pharmacogenomics of antipsychoticsThe Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityHuman leucocyte antigen-adverse drug reaction associations: from a perspective of ethnicity.Pharmacogenomics of off-target adverse drug reactions.Successful clozapine re-challenge in a patient with three previous episodes of clozapine-associated blood dyscrasia.Pharmacogenetics of clozapine treatment response and side-effects in schizophrenia: an update.Establishing the characteristics of an effective pharmacogenetic test for clozapine-induced agranulocytosis.Personalized prescribing: a new medical model for clinical implementation of psychotropic drugs.Psychiatric Pharmacogenomics: How Close Are We?Worldwide Differences in Regulations of Clozapine Use.Hepatic Safety of Atypical Antipsychotics: Current Evidence and Future Directions.Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.Genome-wide association study of lymphoblast cell viability after clozapine exposure.The road to precision psychiatry: translating genetics into disease mechanisms.Incidence and risk estimate of drug-induced agranulocytosis in Hong Kong Chinese. A population-based case-control study.More than 25 years of genetic studies of clozapine-induced agranulocytosis.Clozapine as a Model for Antipsychotic Development.Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.[Dipyrone (metamizole) : Considerations on monitoring for early detection of agranulocytosis].Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.Late Onset Agranulocytosis with Clozapine Associated with HLA DR4 Responding to Treatment with Granulocyte Colony-stimulating Factor: A Case Report and Review of Literature.Evaluating the Effect of the Changes in FDA Guidelines for Clozapine Monitoring.Psychiatric Genomics: An Update and an Agenda.HLAs: Key regulators of T-cell-mediated drug hypersensitivity.Correlation Between Serum Concentrations of N-Desmethylclozapine and Granulocyte Levels in Patients with Schizophrenia: A Retrospective Observational Study.Adverse drug reactions triggered by the common HLA-B*57:01 variant: virtual screening of DrugBank using 3D molecular docking.Biomarkers of adverse drug reactions.Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population.Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapine.Patient ethnicity and the risk of immune-mediated adverse drug reactions.Pathway-Based Analysis of Genome-Wide Association Data Identified SNPs in HMMR as Biomarker for Chemotherapy- Induced Neutropenia in Breast Cancer Patients.Clozapine Pharmacogenetic Studies in Schizophrenia: Efficacy and AgranulocytosisCritical assessment of approaches for molecular docking to elucidate associations of HLA alleles with adverse drug reactionsHow close are we to a pharmacogenomic test for clozapine-induced agranulocytosis?
P2860
Q26787099-A258ECA6-9C42-486A-9E98-D2962563B964Q26800976-9B0830C7-ACDF-4051-BC19-16A68B3705EDQ28066096-22C4BA91-258E-4B6D-AFFF-D9F701B248FBQ28079065-891FDB6F-8720-4424-ACD6-1516AE4B138CQ28080256-DE26E8DC-7483-44E0-BC88-CAD20BEC670DQ28083100-800937DC-BDBE-4EC8-A87C-A9A03651AABCQ30238992-3BBC6AA3-FE46-4225-9237-FF66BFCC35B3Q30400366-85F5BF72-AA79-49E6-9ACA-0DD254E7CDF8Q30490990-16AEF3C2-1018-4821-B30C-49D15125EB10Q35771833-DC34D305-6C8D-4D0C-A805-B802BDFA71BBQ36605131-811B2370-3A39-4883-869C-DF8B27D92EE8Q37344778-85F1EA31-286F-426A-BB3D-0565F0A07652Q37727674-DB6ECFCE-D622-41F2-B69E-E8FD102563ACQ38736547-D995EB15-B551-4D93-9F78-9744DEED9B1CQ38838664-4D0407A6-9863-4BC7-AEBD-7BB1EF958E8BQ38840211-32722F0F-8179-4903-A510-5A686F6FBC8BQ38967700-AFCC1D38-DE6E-46E2-A38E-5CE17094FD21Q38992286-3A402DA2-F228-4D80-B0CE-D72629D63477Q39022892-CE414C49-A14F-435C-9894-7AEA14B6B738Q39247893-0A918437-8242-4C95-83E3-B1705E825E52Q39400094-A4F84683-630C-4F75-8908-4F3F0B9C3408Q39613623-8C0EA1C1-D52D-49BC-BADE-1F1AA692BAF3Q40084051-A3417F2E-4CC0-4D52-9967-CE7DF1952D81Q42072504-6DBEA5BD-987F-4F4A-94DE-3D6FE69259A3Q42562760-D5B53787-1370-4D30-8F5D-01378830D50EQ43258382-A8F7EC21-F74F-415D-9413-4F76D34EF8E8Q46778613-5163347D-4188-4312-99FE-75857A973D3BQ47320133-BA5528FA-4366-48F9-8857-5B1FF4CB1833Q47613439-AE4ED9F6-618F-4B6B-8EC8-A74950E7766DQ47703247-3F7D9985-B25A-41C3-9BB6-55C792740CD7Q47928481-DEA81DD5-865F-480F-B1F0-4B636DE1E7D0Q48026160-609FFF66-68C4-4E46-A714-1B70525484FAQ48314103-6D9B356F-79FD-4AD1-A070-B3363F6DFC57Q49617664-CE64B918-CED4-440E-A570-4990DB8303A8Q52723445-E0940FC7-FF96-4235-965A-E42F12178D8CQ57491589-7C2F67AA-CB9C-47B8-9B92-C805138F7D16Q58774245-5CEDE3F3-7010-4472-9743-6CCCFE0CD072Q59159520-9DE2B3FC-1B96-4DA3-8E18-6F546FB169B7
P2860
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@ast
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@en
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@nl
type
label
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@ast
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@en
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@nl
prefLabel
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@ast
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@en
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@nl
P2093
P2860
P50
P356
P1476
Clozapine-induced agranulocytosis is associated with rare HLA-DQB1 and HLA-B alleles.
@en
P2093
Ana Alfirevic
Anil K Malhotra
Arthur L Holden
Benjamin M Neale
Chris Hilliard
Deanna L Kelly
Deborah L Levy
Edwin J C G van den Oord
Ephraim Gazit
James L Kennedy
P2860
P2888
P356
10.1038/NCOMMS5757
P407
P50
P577
2014-09-04T00:00:00Z
P5875
P6179
1029858229